Well I know that Y! Finance has a $5 12 month price projection and Zacks of $1.25 and rates the stock at a 1 which is excellent. The stock once sold at $13 and is about at its lows. The fundamentals look funky (200 day average at $0.28; total debt way outweigh cash on hand which is typical for a biopharm) at this point. I was thinking of a small position now and see what happens over the next few months. No mutual fund nor institutional investors reported which is a negative to me; there are two big distribution deals in the works....something is up with this company which I cannot figure out at this time. Could be a 4 to 20 bagger in 2013.